Cat
Name
Size
Price
Action
BNC742836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF740 conjugate
500 µL
Ask
BNC401880-100
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate
100 µL
Ask
BNC401865-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), CF640R conjugate
500 µL
Ask
BNC943348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF594 conjugate
100 µL
Ask
BNC942524-500
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), CF594 conjugate
500 µL
Ask
BNCB3309-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), Biotin conjugate
500 µL
Ask
BNC042836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF405S conjugate
100 µL
Ask
BNUM1254-50
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1238 + NAPSA/1239)
50 µL
Ask
BNC473306-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), CF647 conjugate
500 µL
Ask
BNC682524-100
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), CF568 conjugate
100 µL
Ask
BNC042524-100
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), CF405S conjugate
100 µL
Ask
BNC883309-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), CF488A conjugate
100 µL
Ask
BNUB3350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
100 µL
Ask
P1435-5
CA 15-3, Human Breast Adenocarcinoma
5 KU
Ask
BNC943309-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), CF594 conjugate
500 µL
Ask
BNUB3308-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308)
100 µL
Ask
BNC403347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF640R conjugate
100 µL
Ask
BNC882836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF488A conjugate
100 µL
Ask
BNC401880-500
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate
500 µL
Ask
BNC942524-100
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), CF594 conjugate
100 µL
Ask
BNC042576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF405S conjugate
500 µL
Ask
BNUM3348-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
50 µL
Ask
BNCB2576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), Biotin conjugate
100 µL
Ask
BNUB2576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576)
500 µL
Ask
BNCB3350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), Biotin conjugate
100 µL
Ask
BNC473347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF647 conjugate
100 µL
Ask
BNC741865-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), CF740 conjugate
500 µL
Ask
BNC473308-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), CF647 conjugate
100 µL
Ask
BNC043347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF405S conjugate
500 µL
Ask
BNC683350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF568 conjugate
100 µL
Ask
BNUM1865-50
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R)
50 µL
Ask
BNUB2836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836)
100 µL
Ask
BNC942576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF594 conjugate
500 µL
Ask
BNC402836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF640R conjugate
500 µL
Ask
BNC883350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF488A conjugate
500 µL
Ask
BNC681880-500
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF568 conjugate
500 µL
Ask
BNC881865-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), CF488A conjugate
100 µL
Ask
BNC473309-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), CF647 conjugate
500 µL
Ask
BNC473350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF647 conjugate
500 µL
Ask
BNC042576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF405S conjugate
100 µL
Ask
BNUB1254-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1238 + NAPSA/1239)
100 µL
Ask
BNC742524-500
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), CF740 conjugate
500 µL
Ask
BNC683309-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), CF568 conjugate
100 µL
Ask
BNC881880-100
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF488A conjugate
100 µL
Ask
BNC402836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF640R conjugate
100 µL
Ask
BNC743308-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), CF740 conjugate
100 µL
Ask
BNC683347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF568 conjugate
500 µL
Ask
BNUB1880-500
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239)
500 µL
Ask
BNUM3350-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
50 µL
Ask
BNC881254-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1238 + NAPSA/1239), CF488A conjugate
100 µL
Ask
BNC043306-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), CF405S conjugate
500 µL
Ask
BNC043348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF405S conjugate
100 µL
Ask
BNC882524-100
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), CF488A conjugate
100 µL
Ask
BNC403308-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), CF640R conjugate
100 µL
Ask
BNC043350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF405S conjugate
100 µL
Ask
BNCB3347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), Biotin conjugate
500 µL
Ask
BNC473348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF647 conjugate
500 µL
Ask
BNC743309-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), CF740 conjugate
100 µL
Ask
T2235152-1
Paraffin-Tissue-Section---Human-Lung-Tumor:-Adenocarcinoma
5 Slides
Ask
T2235201-1
Paraffin-Tissue-Section---Human-Prostate-Tumor:-Adenocarcinoma
5 Slides
Ask
CAF117
Human Lung Adenocarcinoma CAFs
1000000 Cells
Ask
TR04-RFP
RFP Expressing Human Renal Adenocarcinoma Cells (ACHN)
500000 Cells
Ask
CAF01
Human Endometrial Adenocarcinoma CAFs
1000000 Cells
Ask
BNC041254-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1238 + NAPSA/1239), CF405S conjugate
500 µL
Ask
BNC402576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF640R conjugate
500 µL
Ask
BNCB1865-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), Biotin conjugate
500 µL
Ask
BNC743306-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), CF740 conjugate
100 µL
Ask
BNCB2524-500
Anti-SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), Biotin conjugate
500 µL
Ask
BNC881880-500
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF488A conjugate
500 µL
Ask
BNUB1880-100
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239)
100 µL
Ask
BNC403309-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), CF640R conjugate
500 µL
Ask
BNC401254-500
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1238 + NAPSA/1239), CF640R conjugate
500 µL
Ask
BNC943308-100
Anti-Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), CF594 conjugate
100 µL
Ask
BNC743348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF740 conjugate
500 µL
Ask
BNC941880-100
Anti-Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF594 conjugate
100 µL
Ask
CO245a
Multiple types of colon disease with colon tissue array, including crohn‘s disease, chronic inflammation of the colonic mucosa, ulcerative colitis, adenocarcinoma, 12 cases/24 cores (core size 1.5mm), replacing CO245-CO245a
each
Ask
SM1501
Small intestine ( most of duodenum) adenocarcinoma tissue array with matched NAT or AT as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores-SM1501
each
Ask
PR1211
Prostate adenocarcinoma with hyperplasia and prostate tissue array, including pathology grade, TNM, clinical stage (AJCC 8.0), Gleason grade and Gleason score, 121 cases/121 cores-PR1211
each
Ask
CRC801Sur
Colon adenocarcinoma tissue array with survival data, including pathology grade, TNM and clinical stage (AJCC 8th edition), 80 cases/80 cores-CRC801Sur
each
Ask
CO725
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05041-CO725
each
Ask
RE483
Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases/48 cores-RE483
each
Ask
CO722
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases/72 cores, replacing BC05021-CO722
each
Ask
CO483b
Colon adenocarcinoma with colon tissue array, including pathology, TNM and clinical stage, 48 cases/48 cores, replacing CO483a-CO483b
each
Ask
PR806
Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores-PR806
each
Ask
CO1201
Colon adenocarcinoma tissue array with colon tissue, with pathology grade, TNM/Stage, 120 cases/120 cores ( core size 1.0mm), replacing BC051110c-CO1201
each
Ask
GA751a
Gallbladder adenocarcinoma with adjacent normal gallbladder tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores ( core size 1.5mm), replacing GA751-GA751a
each
Ask
CO352a
Moderately differentiated adenocarcinoma of colon tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores-CO352a
each
Ask
RE1501
Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores-RE1501
each
Ask
PR821
Prostate disease spectrum tissue array, including adenocarcinoma, metastatic carcinoma, hyperplasia, chronic prostatitis, NAT and normal tissue, including pathology grade, TNM /Stage ( AJCC 8th version), Gleason grade and Gleason score, 82 cases/82 cores (core size 1.5mm), replacing PR8011b-PR821
each
Ask
ES8011b
Esophagus adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores (1.5mm), replacing ES8011a-ES8011b
each
Ask
OV802b
Ovary cancer with adjacent normal ovary tissue array (2014 WHO classification), with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV802a-OV802b
each
Ask
BC04119b
Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification)
each
Ask
T091a
Endometrioid adenocarcinoma and normal tissue array, including pathology grade, TNM/Stage (AJCC 8.0), 6 cases/24 cores ( core size 1.5mm), replacing T091-T091a
each
Ask
ST1502
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores-ST1502
each
Ask
REF482
Rectum adenocarcinoma with normal and adjacent rectum tissues, recent years collection, including pathology grade, TNM and clinical stage ( AJCC 8th Edition), 45 cases/48 cores, replacing RE482-REF482
each
Ask
PA1001c
Pancreatic adenocarcinoma with pancreas tissue array
each
Ask
OV20814
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases/208 cores, replacing OV2084-OV20814
each
Ask
LC402
Lung adenocarcinoma with lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 30 cases/40 cores (core size 1.5mm)-LC402
each
Ask
CO953a
Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953-CO953a
each
Ask
BL243a
Bladder cancer with bladder tissue array, including urothelial carcinoma, squamous cell carcinoma, adenocarcinoma and normal tissue, pathololy grade, TNM and clinical stage (AJCC 8.0), 12 case/24 cores (1.5mm), replacing BL243-BL243a
each
Ask